Latest Revenue Model News

NoviqTech’s Coralia has teamed with Swinburne University to explore biochar’s role in reducing embodied carbon in concrete, targeting the booming data centre construction sector.

Advanced Braking Technology Ltd (ASX: ABV) reported a 28% jump in product sales revenue to $6 million for Q3 FY26, driven by strong aftermarket sales and international market traction. The company also advanced certification of its autonomous BRAKEiQ system, targeting FY27 adoption.

Emyria has unveiled the Empax Global Partnership Program, a high-margin clinical delivery platform targeting international drug sponsors amid growing demand for psychedelic-assisted mental health treatments.

Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.

Connexion Mobility reported a record $3 million quarterly revenue, boosted by exclusive software deployment for GM Canada’s Enhanced Exposure Program, while net profit before tax fell 31% due to higher expenses.

Veris Limited has expanded its relationship with Hexagon’s Octave by becoming the authorised geospatial software distributor across Australia and New Zealand, aiming to generate an initial $1.2 million in annual recurring revenue.

icetana AI has secured a $242,000 renewal contract with Curtin University, significantly expanding its camera licence footprint and boosting annual recurring revenue by 85%. The three-year SaaS deal underscores growing demand for campus security and reinforces the company’s recurring revenue model.

Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.

RocketBoots has secured a significant A$3.3 million activation contract with a leading multinational retailer, marking the start of a global deployment phase that complements its existing SaaS agreement and promises near-term revenue growth.

Sims Lifecycle Services (SLS) has emerged as a powerhouse within Sims Group, driving nearly 40% of group earnings through strategic hyperscaler partnerships and capitalising on structural shifts in the memory market.

Cyclopharm has secured a multi-site agreement with Northwestern Medicine, marking a major expansion into Chicago’s healthcare market and reinforcing its US growth strategy.

Peppermint Innovation Limited reported a $1.27 million net loss for the half-year ending December 2025 while achieving key milestones including activation of national payment rails in the Philippines and settling a statutory demand that led to an ASX trading suspension.